Quick Facts

• Therapeutic Domains: Symptom management for asthma and Chronic Obstructive Pulmonary Disease (COPD).
• Core Action: Helps to relax and open air passages within the lungs.
• Use Profile: Intended for ongoing, routine use to help prevent breathing difficulties.

---

Teolin retard, which contains the active substance theophylline, is a medication utilized in the management of chronic respiratory conditions. This established therapeutic option is indicated for addressing the symptoms associated with asthma and other chronic lung diseases, including chronic bronchitis and emphysema.

The primary function is to provide therapeutic support by helping to open the airways in the lungs, which may help manage manifestations such as wheezing, shortness of breath, and chest tightness. It is important to note that this treatment is not intended for the rapid relief of acute, sudden breathing problems, but rather for continuous use to help prevent the recurrence of symptoms. Maintaining consistent use is key for achieving the intended clinical benefit.

The regulatory information for Teolin retard (Theophylline) strictly defines population eligibility based on underlying health conditions and the patient's ability to clear the medicine. Use is permitted primarily in adults and adolescents requiring maintenance therapy for chronic respiratory conditions, provided they have no documented contraindications.

---

Eligibility Status	Key Population Rule
Contraindicated	Patients with known xanthine hypersensitivity, recent acute myocardial infarction (MI), or acute tachyarrhythmia must not use the medicine.
Use Restricted	Use requires extreme caution in populations with severe hepatic impairment (liver failure), as clearance is significantly reduced (ge 50%). Caution is also required for patients with severe hypertension, unstable angina, or uncontrolled seizure disorders.

---

Age-Group Rule	Status
Infants	Contraindicated in children under 6 months of age (in some regulatory documents).
Older Adults	Use with extreme caution in patients over 60 years, as they are at greater risk of toxicity due to potential decreases in clearance.

---

Pregnancy and Lactation Eligibility: Use is not recommended during the first trimester of pregnancy and is generally not recommended while breastfeeding, as theophylline passes into breast milk. Later use in pregnancy is conditional, permitted only if the regulatory-defined benefits outweigh the potential fetal risk.

Connection to the overall eligibility profile: Official regulatory documents define eligibility by establishing absolute prohibitions based on severe cardiovascular risks and hypersensitivity, combined with stringent restrictions for populations where drug clearance is impaired (e.g., liver disease, older age).

Interactions with other medicines and products

Teolin retard, which contains the active ingredient theophylline, has a narrow therapeutic index, making its concentration in the body highly susceptible to changes caused by other products. Due to theophylline's primary metabolism by the Cytochrome P450 (CYP) 1A2 enzyme, interactions generally involve inhibition or induction of this metabolic pathway.

Medicines That May Increase Theophylline Levels (CYP1A2 Inhibitors): Concomitant use with certain medicines may decrease theophylline clearance, increasing its concentration and the risk of toxicity (e.g., seizures, arrhythmias). Examples include some fluoroquinolone antibiotics (e.g., ciprofloxacin), macrolide antibiotics (e.g., erythromycin), H2-receptor antagonists (e.g., cimetidine), and the antidepressant fluvoxamine.

Medicines That May Decrease Theophylline Levels (CYP1A2 Inducers): Use with inducers of CYP1A2 can increase theophylline clearance, leading to lower-than-expected concentrations and potential therapeutic failure. Examples include certain antiepileptic drugs (e.g., phenytoin, phenobarbital, carbamazepine) and the anti-tuberculosis medicine rifampicin. The herbal supplement St. John's wort also decreases theophylline effectiveness.

Other Important Interactions:

• Tobacco Use: Cigarette smoking significantly increases theophylline clearance, requiring higher doses for smokers. Cessation of smoking necessitates a prompt dosage reduction.
• Xanthine Products: Theophylline is a xanthine derivative; therefore, consumption of large amounts of caffeinated products (which are also xanthines) can potentiate side effects.
• Monitoring: Given the potential for clinically significant interactions that alter serum concentrations, Therapeutic Drug Monitoring (TDM) is frequently necessary when starting, stopping, or changing the dose of an interacting medicine.

Mechanism of Smooth Muscle Relaxation via Phosphodiesterase Inhibition

This domain covers Theophylline's primary action as a non-selective competitive inhibitor of Phosphodiesterase (PDE) enzymes, particularly PDE3 and PDE4. By blocking the enzyme responsible for breaking down the intracellular messenger cyclic Adenosine Monophosphate ( cAMP), the drug causes an increase in cAMP concentration within bronchial smooth muscle cells. This molecular cascade leads directly to the relaxation of the airway musculature, resulting in a decrease in intrinsic smooth muscle tension.

Regulation of Inflammatory Gene Expression and Receptor Antagonism

The drug’s second key domain involves two distinct actions on cellular signaling. First, it acts as a non-selective antagonist of Adenosine Receptors ( A1, A2 A, A2 B), thereby blocking the action of an endogenous signaling molecule that influences smooth muscle contraction and mediator release. Second, Theophylline enhances the function of the enzyme Histone Deacetylase-2 ( HDAC2). This molecular enhancement facilitates the functional deactivation of the transcription of genes responsible for pro-inflammatory cytokine production, supporting a shift in the inflammatory gene expression profile.

Teolin retard (theophylline prolonged-release tablets) is strictly for oral administration as part of a long-term maintenance treatment plan for chronic respiratory conditions. To maintain consistent drug levels in the bloodstream, the standard dosing regimen is typically twice daily (every 12 hours), although a once-daily schedule may be used for certain individuals. The medicine can be taken with or without food but should be administered at the same time each day.

To ensure the prolonged-release mechanism functions correctly, the tablets must be swallowed whole and must not be crushed, broken, or chewed. The typical adult maintenance dose often ranges from 400 mg to 600 mg total daily, generally not exceeding 600 mg. Dosage adjustment, or titration, must be performed cautiously and at intervals of no less than three days to allow serum concentrations to reach a steady state, often guided by therapeutic drug monitoring.

Usage instructions include specific rules for certain patient groups. For example, older adults (over 60 years) generally receive a lower total daily dose, often limited to 400 mg per day. In cases of a missed dose, it is recommended to take the dose only if remembered within four hours of the scheduled time; otherwise, it should be skipped to prevent double dosing.

Recent Clinical Evidence Overview

Teolin retard, a sustained-release form of theophylline, has been the subject of multiple clinical studies, primarily within the context of chronic respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). The research focus has included its use as an adjunctive treatment and the maintenance of steady concentration levels.

---

Phase 3 Randomized Controlled Trials (RCTs)

Studies have investigated whether the drug, as an add-on to standard inhaled therapies, might affect clinical outcomes in patients with stable COPD. One large randomized, placebo-controlled trial involving over 1,500 adults with COPD found that adding low-dose theophylline did not reduce the rate of moderate or severe disease exacerbations over a one-year period compared to placebo.

However, other meta-analyses and trials focused on different endpoints and patient groups have shown varied observations, including:

• Changes in Lung Function: Some pooled data from trials reported that the use of theophylline was associated with a measured increase in forced expiratory volume in one second (FEV1).
• Hospital Admissions: Research has suggested that combination therapy protocols involving theophylline may be associated with a reduced rate of COPD-related hospital admissions.

---

Pharmacokinetics and Administration Protocols

Due to the sustained-release formulation, research has also focused on drug absorption. Studies involving Teolin retard specifically have demonstrated complete bioavailability, with food intake not influencing the overall absorption characteristics in the evaluated subjects. The studied protocols most often involved administering the drug orally at a dose of 100mg, taken twice daily, to maintain consistent plasma concentrations.

Common questions about Teolin retard (FAQ)

Q: Is Teolin retard the same as the regular Teolin, or is it different?

A: Teolin retard is an extended-release (or prolonged-release) formulation of the medicine, meaning it is designed to release the active ingredient slowly over a long period. This differs from a standard or immediate-release formulation, which is absorbed more rapidly into the body.

Q: Does Teolin retard cause drowsiness?

A: Official product information does not consistently list drowsiness (feeling sleepy) as a common side effect. However, regulatory documents do frequently report central nervous system side effects such as trouble sleeping (insomnia), restlessness, and tremor.

Q: Are there any specific foods or drinks to avoid while taking Teolin retard?

A: Regulatory documents advise patients to avoid large amounts of caffeinated products such as coffee, tea, cola, and chocolate. These products contain substances called xanthines, which are chemically similar to the medicine and may increase the risk of side effects.

Q: What is the difference between an extended-release medicine and a standard tablet?

A: An extended-release tablet, like Teolin retard, slowly releases the medication over many hours to help maintain stable drug levels throughout the day. A standard, or immediate-release, tablet releases its entire dose quickly, resulting in a rapid peak concentration followed by a quicker drop in levels.

Q: Is it normal to feel a mild headache when first starting Teolin retard?

A: Official documentation indicates that a headache is one of the commonly reported adverse effects of this medication. Concerns about headaches or other adverse effects are generally discussed with a healthcare provider.

Q: Is Teolin retard permitted for use in teenagers?

A: Theophylline is approved for use in teenagers (aged 12 and older) for certain purposes. For younger teenagers or those with lower body weight, the dose may be calculated based on their body mass.

Q: Will Teolin retard interact with my blood pressure medicine?

A: Teolin retard is known to interact with a wide range of medications which can affect its concentration. Official labels caution that the medicine can interact with certain blood pressure medicines. Drug monitoring is sometimes used when starting or changing an interacting medicine.

Q: What is the general expected duration of action for one Teolin retard tablet?

A: The extended-release formulation is designed to release the active ingredient over a prolonged period. This mechanism allows the medication to be administered on a once-a-day or twice-a-day (for example, every 12 hours) schedule to ensure stable drug concentrations are maintained.

Q: Has Teolin retard been studied in children?

A: Yes, the active ingredient in Teolin retard has been studied and is used in children and adolescents. Dosage is highly variable and is often calculated based on age and body weight.

Q: Can Teolin retard be taken with herbal supplements?

A: Regulatory information indicates that theophylline may interact with certain herbal products. For example, the herbal supplement St. John's wort is known to decrease the drug's effectiveness. The disclosure of all herbal products to a healthcare provider is generally recommended due to potential interactions.

Q: Is Teolin retard a commonly prescribed medication?

A: Theophylline, the active ingredient in Teolin retard, is a widely prescribed, prescription-only medication. It is used as a long-term maintenance treatment for chronic respiratory conditions like asthma and COPD.

Q: Can Teolin retard be taken with over-the-counter pain relievers?

A: Because theophylline is susceptible to many drug interactions, official labels require patients to inform their doctor or pharmacist about all prescription and nonprescription (over-the-counter) medications, including pain relievers.

Q: How long does it usually take before Teolin retard starts to feel like it's working?

A: Teolin retard is intended for long-term maintenance and prevention of symptoms, not for immediate relief during an acute breathing problem. The extended-release form typically reaches its highest concentration in the blood several hours after the tablet is taken.

Q: Are there any known issues with taking Teolin retard and birth control pills?

A: Yes, official sources indicate a known interaction. Hormonal contraceptives (birth control pills) may increase the concentration of theophylline in the blood, which can raise the risk of adverse effects or toxicity. Drug monitoring is sometimes used when combining medications that affect theophylline levels.

Q: Is Teolin retard used in individuals with kidney issues?

A: Caution is advised in individuals with kidney issues. Conditions that reduce renal (kidney) function can also impact how the body handles theophylline. Reduced clearance can increase drug levels, and monitoring may be necessary.

Q: Is there a generic version of Teolin retard available?

A: Yes, theophylline (the active ingredient in Teolin retard) is available in generic extended-release tablet and capsule formulations. This means that authorized generic formulations of theophylline are widely available.

Q: How is Teolin retard different from inhaled medicines for breathing?

A: Teolin retard is an oral medication used for long-term daily maintenance of chronic airway conditions. It is not a fast-acting rescue medicine and is not intended for the immediate relief of acute breathing crises, which is the role of certain quick-acting inhaled medications.

Q: Are there different strengths of Teolin retard available?

A: Yes, extended-release formulations of theophylline are available in multiple strengths to allow for personalized dosing based on the patient's needs and blood levels. These strengths typically include tablets or capsules ranging from 100 mg up to 600 mg.

Q: Are there any restrictions on driving or operating machinery while on Teolin retard?

A: Official documents list side effects such as dizziness, tremors, and restlessness. While a mandatory restriction is not universally listed, such nervous system effects are generally considered potentially hazardous to a person's ability to drive or operate machinery.

Q: Does Teolin retard interact with cold and flu medications?

A: Yes, theophylline can interact with certain ingredients commonly found in over-the-counter cold and flu products, such as ephedrine and pseudoephedrine. The disclosure of all prescription and nonprescription drugs to a healthcare provider is generally necessary to manage potential interactions.

How to Store and Dispose of Teolin retard

The storage and disposal of Teolin retard (theophylline extended-release) must comply with official regulatory standards to maintain product stability and ensure public safety.

---

Storage Requirements

Teolin retard must be stored at controlled room temperature, specifically between 20 C and 25 C. The medication requires protection from moisture and must be kept in a tightly closed, well-closed container. To prevent accidental ingestion, the container must have a child-resistant closure and be kept securely out of the sight and reach of children.

Handling and Disposal

The tablets should not be broken or crushed to maintain the extended-release function. Disposal of unused or expired product must strictly follow local, state, and federal regulations. The product should not be emptied into drains or wastewater; utilize an approved waste disposal program or authorized take-back location.